Endocrine Abstracts

The Liver X Receptor (LXR) agonists have been shown to influence the development of hyperlipidemia and atherosclerosis in mouse models. It has also been demonstrated that some LXR agonists can cause hepatic steatosis in experimental animals. GH is also known to regulate hepatic metabolism and absence of the hepatic GH receptors leads to hepatic steatosis. In this study we analyzed whether actions of LXR agonists could involve interference with GH signaling. We showed that LXR ...